Watson Pharmaceuticals (WPI) announces plans to restructure operations at its Corona, California facility. As such, manufacturing and related support functions at the site will be reduced and activities at the facility going forward will be focused only on the production of oral contraceptives. The company anticipates the restructuring to be complete by the end of 2014, and expects to incur related costs of approximately $13M to $16M.
Watson Pharmaceuticals (WPI) announces plans to restructure operations at its Corona, California...
From other sites
Video at CNBC.com (Nov 19, 2015)
Video at CNBC.com (Sep 21, 2015)
Video at CNBC.com (Aug 6, 2015)
Video at CNBC.com (Jul 27, 2015)
at CNBC.com (Feb 18, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs